Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning-Reference-Cited by-同舟云学术

Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning

Published:2021-11 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Saboo Krishnakant^ORCID,Petrakov Nikita V.^ORCID,Shamsaddini Amirhossein^ORCID,Fagan Andrew,Gavis Edith A.,Sikaroodi Masoumeh,McGeorge Sara^ORCID,Gillevet Patrick M.,Iyer Ravishankar K.,Bajaj Jasmohan S.^ORCID

Funder

National Science Foundation

AHRQ

U.S. Department of Veterans Affairs

NCATS

VHA Office of Research and Development

Publisher

Elsevier BV

Subject

Hepatology

Reference27 articles.

1. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?;Hatton;Expert Rev Gastroenterol Hepatol,2019

2. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure;Trebicka;Nat Rev Gastroenterol Hepatol,2021

3. Chronic liver diseases and the microbiome-translating our knowledge of gut microbiota to management of chronic liver disease;Acharya;Gastroenterology,2021

4. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy;Bajaj;Hepatology,2015

5. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation;Bajaj;Am J Physiol Gastrointest Liver Physiol,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment;Gut;2024-08-22

2. Hepatic Encephalopathy—A Guide to Laboratory Testing;Clinics in Liver Disease;2024-05

3. Machine learning-based characterization of the gut microbiome associated with the progression of primary biliary cholangitis to cirrhosis;Microbes and Infection;2024-05

4. Dysbiosis of gut microbiota and metabolites during AIDS: implications for CD4+ T cell reduction and immune activation;AIDS;2023-12-07

5. Pathogenic entero- and salivatypes harbour changes in microbiome virulence and antimicrobial resistance genes with increasing chronic liver disease severity;2023-08-07